The Johnson & Johnson Vaccine Pause Explained

SpaceX, Elon Musk’s rocket and satellite maker, is set to go public and begin selling shares as soon as next week. Ryan Mac, who reports on business, explains the plan for the company’s expected record-shattering debut on the stock market, and how it is changing the rules for inv ...  Show more

In the lead-up to America’s 250th anniversary, President Trump is spending hundreds of millions of dollars on a major renovation of the nation’s capitol. David A. Fahrenthold, who has been investigating how the projects have come together, takes listeners on a walking tour of the ...  Show more

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ...  Show more

The CDC and the FDA have lifted their recommended pause on the Johnson and Johnson COVID vaccine, and added a warning label about the very, very rare reported cases of blood clots. But overall vaccination rates in the US are slowing down, indicating that while supply is increasin ...  Show more

The U.S. Food and Drug administration found the Johnson & Johnson coronavirus vaccine is safe and effective and meets the emergency use authorization requirements. If authorized, it’ll be the third shot option in the United States. Dr. Leana Wen is the former Baltimore Health Com ...  Show more